3Bar Biologics Adds David Nothmann To Board And Chris Koenig As Chief Business Development Officer
For Immediate Release: February 3, 2021 3Bar Biologics Adds David Nothmann To Board And Chris Koenig As Chief Business Development Officer (Columbus, Ohio) – 3Bar Biologics appoints David Nothmann to its board of directors and names Chris Koenig to Chief Business Development Officer to kick-off the year with business growth and development. Nothmann is the […]